Jefferies has PDI at hold

PDI, Inc. was maintained at a hold rating by Jefferies & Co., Inc. analyst David Windley. Jefferies lowered its price target to $10 from $12. The company announced the full termination of the AstraZeneca fee-for-service contract sales program. The analyst lowered its estimates to reflect this contract loss. Shares of the Saddle River, N.J., sales and marketing company were down $1.05, or 9.76%, at $9.71 on volume of 470,137 shares versus the three-month running average of 86,450 shares. (Nasdaq: PDII)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.